Diabetes Board decisions

The Board has remanded the Veteran's claims for service connection due to incomplete records and further development is required.

The Board has granted service connection for non-Hodgkin's lymphoma and type II diabetes mellitus, both presumed to be due to herbicide agent exposure during active service.

The Veteran's claim for service connection for prostate cancer is denied as there is no evidence of a disease or injury in service, and the current disability is not related to service.,Service connection for PTSD is denied because the claimed stressor has not been corroborated by credible supporting evidence.

The Board has determined that the Veteran's currently diagnosed latent autoimmune diabetes in adults is etiologically related to his active duty service, and therefore grants service connection for diabetes mellitus, type I.

The Board has remanded the claims for service connection for various disabilities, including heart disability, hypertension, diabetes mellitus, type II, bilateral peripheral neuropathy of the upper and lower extremities, erectile dysfunction, obstructive sleep apnea, benign prostatic hyperplasia, asthma, and dementia, all claimed as due to Agent Orange exposure. The remand also includes a request for verification of in-service herbicide agent exposure.

The Board has remanded the cases due to insufficient evidence regarding the Veteran's exposure to herbicide agents during service, specifically Agent Orange. The case will be returned for further development.

The Veteran's bilateral hearing loss is currently rated as noncompensable, with no more than Level I in the right ear and no worse than Level II in the left ear.,The Veteran's diabetes mellitus with erectile dysfunction is currently rated as 20 percent disabling. The Board found that the Veteran required only restricted diet and an oral glycemic agent during the period on appeal.,Prior to March 6, 2015, the Veteran's right lower extremity peripheral neuropathy was manifested by no more than mild incomplete paralysis (10% rating). Beginning March 6, 2015, it is now rated as 20% disabling for moderate incomplete paralysis.,Prior to March 6, 2015, the Veteran's left lower extremity peripheral neuropathy was manifested by no more than mild incomplete paralysis (10% rating). Beginning March 6, 2015, it is now rated as 20% disabling for moderate incomplete paralysis.

The Veteran's initial rating for diabetic nephropathy is granted at a 60 percent level, but no higher. The other issues are remanded due to the failure to secure VA treatment records.

The Veteran's claim for service connection for diabetes mellitus was reopened and granted. Service connection for COPD is remanded due to insufficient evidence.

The Board has determined that the Veteran's claims for increased ratings and service connection are remanded due to the need for additional examinations. The effective date claim is denied as there was no earlier claim prior to October 30, 2015.

The Veteran's service-connected disabilities, including diabetes mellitus and its complications, have rendered him unable to secure or follow substantially gainful employment.

The Veteran's claim for service connection for migraine headaches, to include as secondary to her service-connected allergic sinusitis/rhinitis, diabetes mellitus, and/or steroids taken for treatment of asthma, is remanded due to the need for additional medical opinions.

The Veteran's diabetes mellitus Type I has been rated at 20 percent since September 21, 2017. The Board has ordered a remand to determine if the Veteran requires regulation of activities for his diabetes.

The Board has remanded the Veteran's claims for lung cancer, diabetes mellitus, and associated diabetic polyneuropathy of multiple extremities due to potential exposure during service in the Southwest Asia theatre of operations. Additional medical opinions are needed regarding whether these conditions are related to such exposures.

The Veteran's claims for service connection for type II diabetes mellitus, coronary artery disease, hypertension, blood clots, and vasculitis have been denied as there is no evidence of herbicide exposure or in-service injury. The Board found that the Veteran did not serve within Vietnam and thus could not establish exposure to herbicide agents.

The Board has granted service connection for sleep apnea as secondary to the Veteran's service-connected depressive disorder and for diabetes mellitus type II (diabetes) as secondary to his service-connected sleep apnea.

The Veteran's diabetes is presumed to be related to his exposure to toxic herbicide agents during service in the Republic of Vietnam.

The Board found that the Veteran's death was not due to a service-connected disability, and thus denied his claim for service connection for the cause of death.

The Board has determined that the evidence is in equipoise regarding whether the Veteran's diagnosed chronic kidney disease was caused by his service-connected diabetes mellitus, type II. As a result, the claim for service connection for kidney disease secondary to diabetes mellitus, type II is granted.

The Veteran's claims for service connection for depression, high blood pressure, high cholesterol, and diabetes have been dismissed due to the death of the Veteran.